Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Neuropharmacology. 2014 Jul 3;86:38–48. doi: 10.1016/j.neuropharm.2014.06.022

Figure 5.

Figure 5

CeA and BNST peptide immunoreactivities are diminished after PBn lesions. PACAP and CGRP immunoreactivities in the CeA (A) and BNST (B) from studies described in Figure 4 were subjected to image analyses as described in Methods. The PBn lesions decreased PACAP and CGRP immunoreactivities in the limbic regions to a comparable extent compared to levels on the contralateral hemisphere with PBn - vehicle injections. n = 3, data represent mean ∀ SEM. *, different from vehicle control at p < 0.05.